Immune restoration disease after antiretroviral therapy.
about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyNew insights into HIV-1-primary skin disordersThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicPost-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patientIntegrated therapy for HIV and tuberculosisHIV & immune reconstitution inflammatory syndrome (IRIS)Current trends and intricacies in the management of HIV-associated pulmonary tuberculosisNeurological immune reconstitution inflammatory response: riding the tide of immune recoveryIncidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort studyTuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsHIV and Tuberculosis: a Deadly Human SyndemicHospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentThoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.Risk factors for mortality from primary cryptococcosis in patients with HIV.Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolutionRisk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational DatabaseClinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Progressive multifocal leukoencephalopathy in HIV-1 infection.Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy.Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.Confusion in the Study of Immune Reconstitution Inflammatory Syndrome.d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature reviewThe clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan childrenMycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia.Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced diseaseDisseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy.HIV-Associated Tuberculosis.Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
P2860
Q21144623-7BEEDC9E-1F5D-4BD0-9C7A-F26D9E3D631FQ21198772-390645B0-0908-46F1-8E11-8C58350FDED5Q22241890-EE5BD07D-52D2-401A-9B31-16A298EBDF3EQ24544095-B531328B-87DF-48E9-AF3B-BCA0915DF42AQ26749428-CFF500BF-B54D-401A-B4AA-871DC1246B9EQ26852805-3C4A3886-2225-4768-8CEA-98C7D7BE1BFBQ28069032-72EA74F3-9357-4497-9DCD-4178C0982A7BQ28082309-7A3542C5-B28B-47FE-8982-FBFE53F96D1AQ28478173-E8A1B483-572E-4635-9283-C44A7E9BD020Q28749315-7BC97ACC-009E-47C7-B673-417C4C979995Q30052157-00253BF0-90F6-4763-AC83-D1455E6C1DB7Q30252460-1DB342AE-2948-4FC5-81E7-EECAD7B9782FQ30356074-CDCFE1AF-E775-4535-AA0B-897496F2FF87Q30364647-D8EEC66A-F5B7-4B6E-BD70-ED4ECEF2FD66Q32182100-4E0F5D43-F29C-458B-B3EC-4A86ED94B77EQ33157255-0F725AC1-2EE2-41DA-8E23-8257E51F1619Q33301325-92A32E87-A7C3-476A-B4F9-F8510C4075C8Q33433188-08E8662D-6FBA-4E11-B2FB-6ADABD802B62Q33442216-9FEB2DBC-AED7-48AF-ABF6-D8E6C5957D4DQ33506561-44C53196-276F-4D57-9744-8B97117F91FDQ33518021-0948F972-37D8-444F-BB9B-D34124C68F2CQ33593553-57624AF5-0171-48AF-924A-8CAB0357372EQ33605245-34990A57-3113-4B5F-A75D-D1E84970D759Q33686938-DCE86310-3138-4397-8EE6-5CA8C59EFE0BQ33840983-EDD6FBD8-AFA0-4827-B301-1A8115F733ABQ33888707-050D9066-07FC-45E8-BF4F-5CD14A8D714BQ33920429-8C86B413-9777-44AE-B102-F0E2EC69CE64Q33941296-519624D2-3D23-4C17-8E30-E36FC6A795E4Q34003099-57B8F92C-EA33-4324-A37F-92675FBF872EQ34039981-7ED71E03-2D82-498A-9CCF-28F7E8CB46ABQ34079505-A4E1DE77-9E91-4464-8383-F30D111C353DQ34100037-08A14F79-28C7-4EB2-8F23-9820E72A8BDCQ34100670-DB9E476D-09B7-44B5-B00E-F64244C3DE76Q34143510-15BA9A62-C8D5-46A4-83EC-E3CD499BA4A3Q34145129-BEEACF74-76CB-4B88-B3A5-8963B2C7C72BQ34310523-CCC7E779-5A0C-4CA1-B29B-502430F3E760Q34321256-75FF6645-2B0D-4A50-A3CD-F2CD80FDF90EQ34395892-F04F4A06-5C93-40E4-BA26-2AB78ACE302AQ34415055-C915B51D-D45F-4BB2-AF3D-D6C24861AF7AQ34477198-613A1F36-EB57-4B84-9AFF-3098F809C080
P2860
Immune restoration disease after antiretroviral therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immune restoration disease after antiretroviral therapy.
@ast
Immune restoration disease after antiretroviral therapy.
@en
type
label
Immune restoration disease after antiretroviral therapy.
@ast
Immune restoration disease after antiretroviral therapy.
@en
prefLabel
Immune restoration disease after antiretroviral therapy.
@ast
Immune restoration disease after antiretroviral therapy.
@en
P1433
P1476
Immune restoration disease after antiretroviral therapy.
@en
P2093
Patricia Price
Shelley F Stone
P304
P356
10.1097/01.AIDS.0000131375.21070.06
P407
P577
2004-08-01T00:00:00Z